Medtox' drugs-of-abuse device:
This article was originally published in Clinica
Executive Summary
Medtox Scientific's Sure-Screen drugs-of-abuse point-of-collection test (POCT) device that it believes provides significantly lower detection levels for eight commonly abused drugs, compared with other FDA-cleared POCT product. The Sure-Screen device is designed to provide lower detection levels for marijuana, opiates, cocaine, amphetamines, methadone, benzodiazepines, methamphetamines and MDMA-Ecstasy by an average of around 50% each. The St Paul, Minnesota company believes that much lower detection levels will be in demand in markets interested in "zero tolerance".